Sleep Disorders News

A meta-analysis of randomized controlled trials published in Mayo Clinic Proceedings revealed that sleep disturbance is an adverse effect of several drug classes for a variety of conditions, yet the prescription information of these drugs do not fully reflect clinical evidence.

NEW ORLEANS – Immunization with diphtheria, tetanus and whole cell pertussis did not increase or cause recurrence risk for apnea/bradycardia in low birth weight infants, according to an abstract presentation at IDWeek 2016.

As women transition from premenopause through postmenopause, the risk for sleep-disordered breathing increases, longitudinal data suggest.

In patients with CVD and moderate-to-severe obstructive sleep apnea, treatment with continuous positive airway pressure plus the usual care did not reduce CV events compared with the usual treatment alone, according to data from the SAVE trial.

Continuous positive airway pressure devices are "frequently available for sale" on classified advertisement websites, despite the fact that such sales are illegal and may pose significant health risks for second-hand buyers, according to data published in JAMA Internal Medicine.

Sex-specific associations appear to exist between androgens, estradiol and sex hormone-binding globulin and sleep quality, with dehydroepiandrosterone-sulphate linked to wake after sleep onset in women and androstenedione associated with the Epworth Sleepiness Scale in men, according to recent findings.

The Inspire Upper Airway Stimulation device improved obstructive sleep apnea severity, according to findings presented at the SLEEP 2016 annual meeting.

PRAGUE — Lateral decubitus position during sleeping may be the cause of asymmetric IOP increase and visual field damage in glaucoma patients, according to one specialist speaking at the European Glaucoma Society Congress.

Insomnia symptoms were significantly prevalent among female veterans and most commonly occurred among other mental health symptoms, according to data presented at the SLEEP 2016 annual meeting.

The FDA recently granted commercial clearance for the Cerêve Sleep System, a bedside device that cools and pumps fluid to a forehead pad worn through the night, for insomnia.